These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

818 related items for PubMed ID: 30646185

  • 21. Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.
    James JR, Gordon LM, Klein JW, Merrill JO, Tsui JI.
    Subst Abus; 2019; 40(1):11-13. PubMed ID: 29578857
    [Abstract] [Full Text] [Related]

  • 22. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM, McCance-Katz EF.
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [Abstract] [Full Text] [Related]

  • 23. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
    Grove LR, Rao N, Domino ME.
    Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Medicaid participation among practitioners authorized to prescribe buprenorphine.
    Saunders H, Britton E, Cunningham P, Saxe Walker L, Harrell A, Scialli A, Lowe J.
    J Subst Abuse Treat; 2022 Feb; 133():108513. PubMed ID: 34148758
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.
    Saloner B, Levin J, Chang HY, Jones C, Alexander GC.
    JAMA Netw Open; 2018 Aug 03; 1(4):e181588. PubMed ID: 30646116
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. U.S. Survey of factors associated with adherence to standard of care in treating pregnant women with opioid use disorder.
    Howard HG, Freeman K.
    J Psychosom Obstet Gynaecol; 2020 Mar 03; 41(1):74-81. PubMed ID: 31244358
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
    Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE.
    JAMA Netw Open; 2019 Jun 05; 2(6):e196373. PubMed ID: 31251376
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis.
    Knudsen HK, Lin LA, Lofwall MR.
    Subst Abus; 2020 Jun 05; 41(2):259-268. PubMed ID: 31295057
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.